The FDA has warned that it is not clear that transvaginal POP repair with mesh is more effective than traditional non-mesh repair in all patients with POP, and that vaginal mesh may expose patients to greater risk. Still mesh is used widely across Champaign-Urbana and Central Illinois.
The FDA issued this warning because mesh has been shown to erode into the vaginal walls. It may also tighten or shift, causing it to protrude into the vaginal canal. In certain women, the mesh begins to cause injury only a year after surgery.
Injured women may experience:
- Erosion, and possible exposure or extrusion, of mesh through vaginal tissue
- Perforation of pelvic organs, bowels and blood vessels
- Pelvic pain and difficulty moving
- Abdominal pressure
- Recurrence of POP
- Vaginal discharge and infections
- Vaginal bleeding
- Vagina scarring or shortening
- Urinary incontinence